Cambridge Investment Research Advisors, Inc. Medtronic PLC Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 187,228 shares of MDT stock, worth $15.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

187,228

Previous 187,737 0.27%

Holding current value

$15.1 Million

Previous $14.8 Million 14.07%

% of portfolio

0.06%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$76.84 - $91.03 $39,111 - $46,334	-509 Reduced 0.27%	187,228 $16.9 Million
Q2 2024 Jul 26, 2024	SELL	$78.71 - $87.02 $427,946 - $473,127	-5,437 Reduced 2.81%	187,737 $14.8 Million
Q1 2024 Apr 24, 2024	BUY	$82.84 - $88.09 $65,609 - $69,767	792 Added 0.41%	193,174 $16.8 Million
Q4 2023 Feb 09, 2024	BUY	$69.43 - $83.43 $523,710 - $629,312	7,543 Added 4.08%	192,382 $15.8 Million
Q3 2023 Oct 24, 2023	SELL	$78.22 - $90.4 $120,693 - $139,487	-1,543 Reduced 0.83%	184,839 $14.5 Million
Q2 2023 Jul 13, 2023	BUY	$79.47 - $91.38 $91,787 - $105,543	1,155 Added 0.62%	186,382 $16.4 Million
Q1 2023 May 11, 2023	BUY	$76.72 - $87.58 $2.42 Million - $2.76 Million	31,512 Added 20.5%	185,227 $14.9 Million
Q4 2022 Feb 08, 2023	SELL	$76.18 - $87.74 $34,204 - $39,395	-449 Reduced 0.29%	153,715 $11.9 Million
Q3 2022 Oct 17, 2022	BUY	$80.75 - $95.31 $426,521 - $503,427	5,282 Added 3.55%	154,164 $12.4 Million
Q2 2022 Jul 13, 2022	BUY	$87.4 - $113.09 $760,205 - $983,656	8,698 Added 6.2%	148,882 $13.4 Million
Q1 2022 May 12, 2022	SELL	$100.58 - $112.38 $135,883 - $151,825	-1,351 Reduced 0.95%	140,184 $15.6 Million
Q4 2021 Feb 03, 2022	BUY	$99.53 - $127.75 $1.09 Million - $1.4 Million	10,957 Added 8.39%	141,535 $14.6 Million
Q3 2021 Nov 02, 2021	BUY	$122.75 - $135.17 $151,596 - $166,934	1,235 Added 0.95%	130,578 $16.4 Million
Q2 2021 Aug 10, 2021	BUY	$118.19 - $131.5 $327,859 - $364,781	2,774 Added 2.19%	129,343 $16.1 Million
Q1 2021 May 07, 2021	BUY	$111.18 - $119.74 $916,456 - $987,016	8,243 Added 6.97%	126,569 $15 Million
Q4 2020 Feb 04, 2021	SELL	$100.57 - $117.14 $1.4 Million - $1.64 Million	-13,967 Reduced 10.56%	118,326 $13.9 Million
Q3 2020 Oct 29, 2020	SELL	$90.13 - $108.78 $3.87 Million - $4.67 Million	-42,924 Reduced 24.5%	132,293 $13.7 Million
Q2 2020 Jul 27, 2020	BUY	$84.11 - $103.33 $446,035 - $547,958	5,303 Added 3.12%	175,217 $16.1 Million
Q1 2020 May 08, 2020	SELL	$72.92 - $121.3 $407,549 - $677,945	-5,589 Reduced 3.18%	169,914 $15.3 Million
Q4 2019 Feb 04, 2020	BUY	$104.49 - $114.54 $6.4 Million - $7.02 Million	61,295 Added 53.67%	175,503 $19.9 Million
Q3 2019 Nov 06, 2019	BUY	$98.02 - $111.18 $1.53 Million - $1.74 Million	15,652 Added 15.88%	114,208 $12.4 Million
Q3 2019 Oct 28, 2019	SELL	$98.02 - $111.18 $980 - $1,111	-10 Reduced 0.01%	98,556 $10.7 Million
Q2 2019 Aug 15, 2019	BUY	$84.15 - $99.38 $790,168 - $933,178	9,390 Added 10.53%	98,566 $0
Q1 2019 May 08, 2019	BUY	$82.45 - $93.79 $390,400 - $444,095	4,735 Added 5.61%	89,176 $0
Q4 2018 Feb 05, 2019	BUY	$85.8 - $99.49 $255,169 - $295,883	2,974 Added 3.65%	84,441 $7.68 Million
Q3 2018 Nov 02, 2018	BUY	$85.91 - $99.17 $334,447 - $386,068	3,893 Added 5.02%	81,467 $0
Q2 2018 Aug 10, 2018	BUY	$77.48 - $87.83 $562,427 - $637,557	7,259 Added 10.32%	77,574 $0
Q1 2018 May 09, 2018	BUY	$76.55 - $87.26 $505,612 - $576,352	6,605 Added 10.37%	70,315 $0
Q4 2017 Feb 22, 2018	BUY	$76.93 - $83.5 $699,216 - $758,931	9,089 Added 16.64%	63,710 $0
Q3 2017 Nov 07, 2017	BUY	$77.71 - $84.6 $246,573 - $268,435	3,173 Added 6.17%	54,621 $4.25 Million
Q2 2017 Aug 08, 2017	BUY	N/A	51,448	51,448 $4.57 Million

Others Institutions Holding MDT

# of Institutions

2,286

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $107B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Medtronic PLC Transaction History